Suscribirse

Evaluation of perfusate composition correction during 12-hour ex-vivo lung perfusion in swine - 08/04/25

Doi : 10.1016/j.rmr.2025.02.028 
J. Mercier 1, , J. Issard 2, P. Mordant 3, 4, G. Fadel 1, 2, MR. Ghigha 2, E. Fadel 2, F. Antigny 1, O. Mercier 2
1 Université Paris-Saclay, Inserm, Hypertension Pulmonaire, Physiopathologie et innovation thérapeutique, 92350 Le Plessis Robinson, France 
2 Department of Thoracic and Vascular Surgery and Lung and Heart-Lung Transplantation, Marie-Lannelongue Hospital, Groupe Hospitalier Paris-Saint-Joseph, Le Plessis Robinson, France 
3 Université Paris Cité and Université Sorbonne Paris Nord, Inserm, LVTS, F-75018 Paris, France 
4 Service de Chirurgie vasculaire, Thoracique et transplantation Pulmonaire, AP-HP, Hôpital Bichat – Claude Bernard, F-75018 Paris, France 

Auteur correspondant.

Resumen

Introduction

Ex vivo lung perfusion (EVLP) is a preservation technique that allows the evaluation and reconditioning of marginal donor grafts, thereby expanding the donor pool. However, EVLP is currently limited to 6hours in clinical practice and at least 30 % of grafts fail to meet transplantation criteria at the end of perfusion period [1]. Today, EVLP is mainly used to assess lung function before lung transplantation rather than to recondition damaged lungs. We aim to prolong the duration of EVLP as this would allow the application of therapies and potentially increase the number of lungs available for transplantation. We hypothesize that maintaining pH, electrolytes, and glucose levels in the perfusate would allow EVLP for more than 6hours while preserving organ integrity. Thus, we investigated the effect of a perfusate correcting solution during a 12-hour EVLP in a porcine model.

Methods

Twelve porcine lung blocks were collected and cold-preserved prior to 12hours of normothermic EVLP. The lung blocks were allocated equally into two groups, according to the perfusate solution. All lung blocks were perfused with STEEN solution™, 100mL of which was replaced every two hours with either fresh STEEN solution™ (standard group, n=6) or a modified solution (1/3 STEEN solution™, 1/3 glucose solution [2.5 %], 1/3 sodium bicarbonate solution [14mg/mL]) designed to correct the perfusate composition (corrected group, n=6). Perfusate electrolytes, glucose, cytokines, pH, partial oxygen pressure (PO2), pulmonary vascular resistance (PVR), and compliance were measured. After the EVLP period, the left lungs were transplanted into donor-related pigs. The right lungs were used for histology and electron microscopy.

Results

During EVLP, perfusate correction succeeded in maintaining electrolyte and pH, within physiological ranges. However, glycemia increased at a higher level than expected. Higher density of Kohn's pores, as well as less edema and more hyaline membranes, were observed in the corrected group after EVLP. Lung compliance and oxygenation tend to be higher in the corrected group without reaching significance. PVR was similar in both groups, and no significant difference was observed in ΔPO2 between groups after transplantation.

Conclusion

We succeeded in correcting perfusate electrolytes levels and pH, but not maintaining glycemia in physiological ranges. In these conditions, no benefit was clearly demonstrated in the corrected group, while some histological changes occured. Further studies are needed to properly correct perfusate composition and maintain glucose levels within physiological ranges. Thus, the effect of an efficient perfusate composition correction on the duration of EVLP remains unknown and still needs to be investigated.

El texto completo de este artículo está disponible en PDF.

Esquema


© 2025  Publicado por Elsevier Masson SAS.
Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 42 - N° 4

P. 195-196 - avril 2025 Regresar al número
Artículo precedente Artículo precedente
  • Design of experiments assisted optimization of induced Pluripotent Stem Cell (iPSC) directed differentiation toward airway progenitors
  • A. Coeur, C. Bourdais, M. Nadaud, F. Foisset, C. Urena, I. Vachier, S. Assou, A. Bourdin, J. De Vos
| Artículo siguiente Artículo siguiente
  • Étude du rejet médié par les lymphocytes natural Killer en transplantation pulmonaire
  • M. Leveque, S. Corgnac, O. Mercier, E. Fadel, G. Dauriat, P. Pradere, M. Phayanouvong, J. Le Pavec, J. Adam

¿Ya suscrito a @@106933@@ revista ?